{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T12:18:56Z","timestamp":1788265136938,"version":"build-2803163510"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Antibiotic exposure is highly prevalent in the paediatric intensive care unit (PICU) and constitutes a major modifiable driver of gut microbiota dysbiosis. However, a systematic synthesis focusing specifically on the PICU population has been lacking. This narrative review addresses how antibiotic exposure drives gut dysbiosis in the PICU, its clinical consequences with emphasis on immunological pathways, and its management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This review was informed by a structured search of PubMed, Web of Science, Cochrane Library, and Chinese databases up to June 2026, including studies on antibiotic exposure, microbiota alterations, clinical outcomes, and management in critically ill children.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Antibiotic use in PICU children ranges from 58% to 94%, with broad-spectrum and combination therapy being common. Anti-anaerobic antibiotics\u2014particularly piperacillin-tazobactam, meropenem, and clindamycin\u2014cause the most pronounced disruption, as quantified in adult ICU cohorts. In PICU children, clinical consequences include a higher incidence of Clostridioides difficile infection and an increased risk of ventilator-associated pneumonia following carbapenem exposure. Antibiotic stewardship, encompassing de-escalation and avoidance of unnecessary anaerobic coverage, is the first-line microbiota protection strategy. Probiotics reduce ventilator-associated pneumonia and shorten PICU stay, but should not be used routinely in high-risk children. High-fibre enteral nutrition has shown feasibility, whereas postbiotics and faecal microbiota transplantation lack PICU-specific trial data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Antibiotics are among the most significant modifiable drivers of gut dysbiosis in the PICU, with dose-dependent, class-specific effects. Antibiotic stewardship should be prioritised before any microbiota-directed intervention. Live probiotics require caution in high-risk populations, while non-live interventions are promising but need larger trials. Future research should employ longitudinal, multicentre studies with standardised reporting to elucidate host\u2013microbe interactions in critically ill children.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1910105","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:49:36Z","timestamp":1788263376000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Antibiotic-induced gut microbiota dysbiosis in the PICU: mechanisms, clinical outcomes, and management strategies \u2013 a narrative review"],"prefix":"10.3389","volume":"17","author":[{"given":"Cheng","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Paediatric Intensive Care Unit Nursing, West China Second University Hospital, Sichuan University","place":["Chengdu, China"]},{"name":"Department of Paediatric Intensive Care Unit Nursing, WCSUH-Tianfu\u00b7Sichuan Provincial Children\u2019s Hospital","place":["Meishan, China"]},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Wang","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Chengdu Medical College, Nuclear Industry 416 Hospital","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Nursing, West China Second University Hospital, Sichuan University","place":["Chengdu, China"]},{"name":"Department of Nursing, WCSUH-Tianfu\u00b7Sichuan Provincial Children\u2019s Hospital","place":["Meishan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/MCC.0000000000001249","article-title":"Gut microbiota and its impact on critical illness","volume":"31","author":"Battaglini","year":"2025","journal-title":"Curr Opin Crit Care"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.21037\/tp-20-349","article-title":"Enteral feeding and the microbiome in critically ill children: a narrative review","volume":"10","author":"Fan","year":"2021","journal-title":"Transl Pediatr"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac698","article-title":"Antibiotic indications and appropriateness in the pediatric intensive care unit: A 10-center point prevalence study","volume":"76","author":"Chiotos","year":"2023","journal-title":"Clin Infect Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-025-08106-6","article-title":"Antibiotics with anaerobic coverage are associated with disproportionate gut microbiota disruption in ICU patients: a multi-centre, longitudinal observational study","volume":"51","author":"Taylor","year":"2025","journal-title":"Intensive Care Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2023.56","article-title":"Appropriateness of antibiotic prescribing varies by clinical services at United States children's hospitals","volume":"44","author":"Diggs","year":"2023","journal-title":"Infect Control Hosp Epidemiol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2024.107731","article-title":"Teleconsultation for infectious disease management in pediatric intensive care","volume":"152","author":"Ceradini","year":"2025","journal-title":"Int J Infect Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/children11060731","article-title":"Antibiotic exposure of critically ill children at a tertiary care paediatric intensive care unit in Switzerland","volume":"11","author":"Fenner","year":"2024","journal-title":"Children (Basel)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/frmbi.2023.1180565","article-title":"The impact of neonatal intensive care unit antibiotics on gut bacterial microbiota of preterm infants: a systematic review","volume":"2","author":"Mulinge","year":"2023","journal-title":"Front Microbiomes"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.97751","article-title":"The impact of different antimicrobial exposures on the gut microbiome in the ARMORD observational study","volume":"13","author":"Peto","year":"2025","journal-title":"Elife"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.12467\/j.issn.2096-3882.20240666","article-title":"Early effects of antibiotics on gut microbiota in very preterm infants","volume":"44","author":"Ning","year":"2024","journal-title":"J Xuzhou Med Univ"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1742512","article-title":"Brief early antibiotic exposure (\u22642 days) is not associated with disruption of gut microbiome in very low birth weight infants","volume":"16","author":"Aoki","year":"2025","journal-title":"Front Microbiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nutos.2023.12.002","article-title":"An open-label pilot single-subject study to monitor the impact of a Food-Based enteral formula on faecal short-chain fatty acid concentrations in children admitted to intensive care with sepsis","volume":"53","author":"O'Connor","year":"2024","journal-title":"Clin Nutr Open Sci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1186\/s12879-024-09735-w","article-title":"Prior carbapenem exposure increases the incidence of ventilator-associated pneumonia in critically ill children","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Infect Dis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1237993","article-title":"Pediatric intensive care unit treatment alters the diversity and composition of the gut microbiota and antimicrobial resistance gene expression in critically ill children","volume":"14","author":"Xu","year":"2023","journal-title":"Front Microbiol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines14051080","article-title":"Quantifying the silent selection pressure: Antimicrobial stewardship and gut microbiome integrity in the NICU and PICU","volume":"14","author":"Herawati","year":"2026","journal-title":"Biomedicines"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/jpbs.jpbs_485_24","article-title":"A hospital-based analytical study on antibiotic utilization in pediatric patients and antibiotic stewardship","volume":"17","author":"Rahman","year":"2025","journal-title":"J Pharm Bioallied Sci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2020.1870402","article-title":"Association between antibiotics and gut microbiome dysbiosis in children: systematic review and meta-analysis","volume":"13","author":"McDonnell","year":"2021","journal-title":"Gut Microbes"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1017\/ash.2025.10054","article-title":"Association between in-hospital antibiotic use and long-term outcomes in critically ill patients","volume":"5","author":"Burrows","year":"2025","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1456793","article-title":"Microbiota-derived short chain fatty acids in pediatric health and diseases: from gut development to neuroprotection","volume":"15","author":"Hsu","year":"2024","journal-title":"Front Microbiol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/idr17020031","article-title":"The global burden of Clostridioides difficile infections, 2016-2024: A systematic review and meta-analysis","volume":"17","author":"Akorful","year":"2025","journal-title":"Infect Dis Rep"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2023.174","article-title":"Incidence and risk factors for recurrent Clostridioides difficile infection in pediatric at-risk groups in selected Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) hospitals","volume":"45","author":"Baldassarre","year":"2024","journal-title":"Infect Control Hosp Epidemiol"},{"key":"B22","unstructured":"Healthcare-Associated Infections: Clostridioides Difficile Infection"},{"key":"B23","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3760\/cma.j.cn112139-20240528-00259","article-title":"Chinese guideline for diagnosis, treatment and prevention of Clostridioides difficile infection (2024)","volume":"62","year":"2024","journal-title":"Chin J Surg"},{"key":"B24","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s44253-025-00106-0","article-title":"Probiotics in critically ill children: a systematic review and meta-analysis of randomized controlled trials","volume":"3","author":"Wang","year":"2025","journal-title":"Intensive Care Med Paediatr Neonatal"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.51847\/8k1tg176ra","article-title":"Clinical pharmacist participation improved the cost-effectiveness of antibiotic treatment in a pediatric intensive care unit","volume":"13","author":"Sauriasari","year":"2023","journal-title":"J Adv Pharm Educ Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-097515","article-title":"Cost savings of a nationwide project preventing healthcare-associated infections in adult, paediatric and neonatal critical care settings in Brazil: a micro-costing study","volume":"15","author":"Bass","year":"2025","journal-title":"BMJ Open"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1177\/00185787241303035","article-title":"Cost implication of inappropriate empiric antibiotics in gram-negative infections","volume":"60","author":"Juang","year":"2025","journal-title":"Hosp Pharm"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2025.155361","article-title":"Seven days versus extended duration antibiotic therapy for multidrug-resistant gram-negative bacterial infections in critically ill patients: A pooled analysis of the OPTIMISE and REGARD-VAP trials","volume":"92","author":"Umer","year":"2026","journal-title":"J Crit Care"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2023.154346","article-title":"Short-course versus prolonged-course antibiotic regimens for ventilator-associated pneumonia: A systematic review and meta-analysis of randomized controlled trials","volume":"78","author":"Cheema","year":"2023","journal-title":"J Crit Care"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1056\/NEJMx180006","article-title":"Trial of short-course antimicrobial therapy for intraabdominal infection","volume":"372","author":"Sawyer","year":"2015","journal-title":"N Engl J Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2025.02.010","article-title":"Revisiting antimicrobial stewardship in the paediatric intensive care unit: insights from an unconventional approach","volume":"160","author":"Liberati","year":"2025","journal-title":"J Hosp Infect"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2025.107507","article-title":"Procalcitonin-guided early cessation of antibiotics prevents gut inflammation and preserves gut microbiome: Data from the PROGRESS controlled trial","volume":"66","author":"Kyriazopoulou","year":"2025","journal-title":"Int J Antimicrob Agents"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103543","article-title":"Shorter or biomarker-guided antibiotic durations for common serious neonatal infections: a collection of non-inferiority meta-analyses","volume":"89","author":"Dutta","year":"2025","journal-title":"EClinicalMedicine"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1136\/bmjoq-2017-000180","article-title":"Impact of pharmacist-led antibiotic stewardship program in a PICU of low\/middle-income country","volume":"7","author":"Haque","year":"2018","journal-title":"BMJ Open Qual"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-025-04072-3","article-title":"Incidence of probiotic sepsis and morbidity risk in premature infants: a meta-analysis","author":"Feldman","year":"2025","journal-title":"Pediatr Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000005580","article-title":"Probiotics in critical illness: A systematic review and meta-analysis of randomized controlled trials","volume":"50","author":"Sharif","year":"2022","journal-title":"Crit Care Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1910105\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:49:39Z","timestamp":1788263379000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1910105\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":36,"alternative-id":["10.3389\/fimmu.2026.1910105"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1910105","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"article-number":"1910105"}}